BioCardia Inc (BCDA)
2.94
+0.18
(+6.52%)
USD |
NASDAQ |
Sep 27, 16:00
2.91
-0.03
(-1.02%)
After-Hours: 20:00
BioCardia Free Cash Flow: -7.108M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -7.108M |
| March 31, 2024 | -8.946M |
| December 31, 2023 | -9.986M |
| September 30, 2023 | -11.13M |
| June 30, 2023 | -10.74M |
| March 31, 2023 | -10.26M |
| December 31, 2022 | -10.63M |
| September 30, 2022 | -10.65M |
| June 30, 2022 | -11.29M |
| March 31, 2022 | -11.51M |
| December 31, 2021 | -10.48M |
| September 30, 2021 | -10.88M |
| June 30, 2021 | -11.85M |
| March 31, 2021 | -11.30M |
| December 31, 2020 | -12.39M |
| September 30, 2020 | -12.23M |
| June 30, 2020 | -10.10M |
| March 31, 2020 | -10.07M |
| December 31, 2019 | -9.591M |
| September 30, 2019 | -9.594M |
| June 30, 2019 | -10.12M |
| March 31, 2019 | -10.61M |
| December 31, 2018 | -11.14M |
| September 30, 2018 | -10.43M |
| June 30, 2018 | -10.20M |
| Date | Value |
|---|---|
| March 31, 2018 | -9.506M |
| December 31, 2017 | -8.807M |
| September 30, 2017 | -17.37M |
| June 30, 2017 | -10.02M |
| March 31, 2017 | -7.949M |
| December 31, 2016 | -5.522M |
| September 30, 2016 | 5.711M |
| June 30, 2016 | 0.184M |
| March 31, 2016 | 0.327M |
| December 31, 2015 | 0.331M |
| September 30, 2015 | 0.27M |
| June 30, 2015 | 0.287M |
| March 31, 2015 | 0.276M |
| December 31, 2014 | 0.214M |
| September 30, 2014 | 0.193M |
| June 30, 2014 | 0.132M |
| March 31, 2014 | 0.068M |
| December 31, 2013 | 0.027M |
| September 30, 2013 | 0.44M |
| June 30, 2013 | 0.385M |
| March 31, 2013 | -0.298M |
| December 31, 2012 | -0.31M |
| September 30, 2012 | -1.564M |
| June 30, 2012 | -1.416M |
| March 31, 2012 | -2.64M |
Free Cash Flow Range, Past 5 Years
-12.39M
Minimum
Dec 2020
-7.108M
Maximum
Jun 2024
-10.54M
Average
-10.64M
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals Inc | 318.87M |
| Theriva Biologics Inc | -18.01M |
| Zevra Therapeutics Inc | -56.06M |
| PetIQ Inc | 11.98M |
| Instil Bio Inc | -52.81M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.312M |
| Cash from Investing (Quarterly) | -0.003M |
| Cash from Financing (Quarterly) | 1.787M |
| Free Cash Flow Per Share (Quarterly) | -0.7006 |
| Free Cash Flow to Equity (Quarterly) | -1.315M |
| Free Cash Flow Yield | -148.9% |